<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02386449</url>
  </required_header>
  <id_info>
    <org_study_id>000180</org_study_id>
    <nct_id>NCT02386449</nct_id>
  </id_info>
  <brief_title>A Study Comparing Picoprep With Mannitol and Bisacodyl for Colon Cleansing in Preparation for Colonoscopy</brief_title>
  <acronym>CLEAR PREP</acronym>
  <official_title>A Randomized, Controlled, Parallel Group, Assessor-Blinded Study To Compare The Efficacy, Tolerability, And Safety Of Oral Sodium Picosulfate (PicoPrep®) Versus Oral Mannitol and Bisacodyl, For Colon Cleansing In Colonoscopy Preparation Of Adult Outpatients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ferring Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ferring Pharmaceuticals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, controlled, parallel group, assessor-blinded study to compare two colon
      cleansing preparations for colonoscopy. Subjects meeting all inclusion and exclusion criteria
      will be randomized and assigned to one of two study groups: Group I (PicoPrep) or Group II
      (Mannitol). In Group I, subjects will take one sachet of PicoPrep on the day before
      colonoscopy, and another sachet on the day of colonoscopy. In Group II, subjects will take
      Bisacodyl on the day before colonoscopy, and Mannitol on the day of colonoscopy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of subjects classified as success (Aronchick scale)</measure>
    <time_frame>At visit 2 (day 1 of colonoscopy)</time_frame>
    <description>Defined as excellent or good according to the Aronchick scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of subjects classified as success (Ottawa scale)</measure>
    <time_frame>At visit 2 (day 1 of colonoscopy)</time_frame>
    <description>Defined as excellent, good or fair according to the Ottawa scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aggregate Tolerability Score (Colonoscopy Preparation Subject Tolerability Questionnaire)</measure>
    <time_frame>At visit 2 (day 1 of colonoscopy)</time_frame>
    <description>As assessed by a Colonoscopy Preparation Subject Tolerability Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject satisfaction (Likert scale)</measure>
    <time_frame>At visit 2 (day 1 of colonoscopy)</time_frame>
    <description>As assessed by a subject survey using a 3 point Likert scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">184</enrollment>
  <condition>Bowel Preparation</condition>
  <arm_group>
    <arm_group_label>Picoprep</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>sodium picosulfate, magnesium oxide and citric acid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mannitol and Bisacodyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sodium picosulfate, magnesium oxide and citric acid (Picoprep®)</intervention_name>
    <arm_group_label>Picoprep</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>mannitol</intervention_name>
    <arm_group_label>Mannitol and Bisacodyl</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bisacodyl</intervention_name>
    <arm_group_label>Mannitol and Bisacodyl</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men or women aged 18 to 60 years

          -  Subjects scheduled for an elective colonoscopy

          -  Women of child-bearing potential using at least one highly effective contraceptive
             method

          -  Subjects able to understand all instructions

          -  Informed consent signed

        Exclusion Criteria:

          -  Hypersensitivity to active ingredients

          -  Female participants pregnant or with a positive blood pregnancy test

          -  Acute surgical abdomen

          -  Previous colorectal surgery

          -  Gastrointestinal (GI) surgery

          -  GI diseases, active inflammatory bowel disease, colon disease

          -  Ascites/hepatic cirrhosis, cardiac disease, advanced pulmonary or renal disease

          -  Use of laxatives or antidiarrheal agents 72 hours prior to screening

          -  Significant alterations in laboratory values or other diseases that could interfere
             with the results
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Development Support</last_name>
    <role>Study Director</role>
    <affiliation>Ferring Pharmaceuticals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (there may be other sites in this country)</name>
      <address>
        <city>Sao Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2015</study_first_submitted>
  <study_first_submitted_qc>March 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2015</study_first_posted>
  <last_update_submitted>January 11, 2016</last_update_submitted>
  <last_update_submitted_qc>January 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mannitol</mesh_term>
    <mesh_term>Bisacodyl</mesh_term>
    <mesh_term>Picosulfate sodium</mesh_term>
    <mesh_term>Magnesium Oxide</mesh_term>
    <mesh_term>Citric Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

